Glenn Garry
About Glenn Garry
Glenn Garry serves as the Sr. Director of National Accounts at Ardelyx, Inc., bringing over two decades of experience in healthcare marketing and managed markets. He has previously held significant roles at AstraZeneca and Amgen, where he developed expertise in patient access programs and reimbursement processes across various payor types.
Work at Ardelyx
Glenn Garry currently serves as the Senior Director of National Accounts at Ardelyx, Inc., a position he has held since 2023. In this role, he focuses on developing and managing national account strategies to enhance patient access to therapies. His responsibilities include collaborating with various stakeholders to ensure effective market penetration and reimbursement processes.
Previous Experience at AstraZeneca
Before joining Ardelyx, Glenn Garry worked at AstraZeneca as the Marketing Director for National Managed Markets from 1992 to 2000. During his eight years in this role, he was involved in strategic marketing initiatives aimed at improving access to AstraZeneca's products within managed care environments.
Career at Amgen
Glenn Garry had a significant tenure at Amgen, where he held multiple roles. He served as Director of Marketing for Payer and Managed Markets from 2008 to 2011, followed by a position as Sales Planning Director from 2011 to 2014. He then advanced to Director of National Accounts, a role he held from 2014 until 2023. His experience at Amgen contributed to his expertise in payer marketing and managed market strategies.
Education and Expertise
Glenn Garry earned a Bachelor of Science in Education with Honors from the University of South Dakota. His educational background supports his extensive experience in the healthcare sector, particularly in reimbursement processes for oral and injectable products across various payer types, including Medicaid and Medicare.
Core Competencies and Specializations
Glenn Garry possesses core competencies in marketing strategy, payer marketing, and patient access programs. He specializes in therapeutic areas such as nephrology, oncology, and cardiovascular health. His expertise in channel distribution and life cycle management has been foundational to his success in sales and account leadership.